Screener
Tvardi Therapeutics TVRD Q2 2026 earnings
Reported August 13, 2026 · Before market open
EPS-$0.69Beat by $0.01
EPS estimate-$0.70
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did Tvardi Therapeutics report Q2 2026 earnings?
- Tvardi Therapeutics (TVRD) reported Q2 2026 earnings on August 13, 2026 before market open.
- What were Tvardi Therapeutics's Q2 2026 revenue and EPS?
- Tvardi Therapeutics reported eps of $-0.69 for Q2 2026.
- Did Tvardi Therapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.70 by $0.01.
- How did Tvardi Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 31.0% from $-1.00.
- Where can I find Tvardi Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-096417) and the 10-Q periodic report (0001104659-26-096424) directly on SEC EDGAR. The filing index links above go to sec.gov.
